A detailed history of Hsbc Holdings PLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 33,296 shares of OCGN stock, worth $22,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,296
Previous 30,633 8.69%
Holding current value
$22,641
Previous $30,000 13.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.72 - $1.08 $1,917 - $2,876
2,663 Added 8.69%
33,296 $26,000
Q3 2024

Nov 14, 2024

BUY
$0.98 - $1.95 $30,020 - $59,734
30,633 New
30,633 $30,000
Q2 2022

Aug 11, 2022

SELL
$1.83 - $3.45 $7,115 - $13,413
-3,888 Reduced 23.37%
12,746 $30,000
Q1 2022

May 16, 2022

BUY
$2.34 - $4.72 $341 - $689
146 Added 0.89%
16,634 $55,000
Q4 2021

Feb 11, 2022

BUY
$4.38 - $15.67 $72,217 - $258,366
16,488 New
16,488 $75,000
Q3 2021

Nov 12, 2021

SELL
$6.36 - $8.51 $71,492 - $95,660
-11,241 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$5.52 - $15.68 $62,050 - $176,258
11,241 New
11,241 $90,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $147M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.